Clinical trial
Medication in Early Diabetes (MED) Study
NCT00437970 · Menzies School of Health Research, Other · Withdrawn
Key facts
| NCT number | NCT00437970 |
|---|---|
| Title | Medication in Early Diabetes (MED) Study |
| Official title | Drug naïve Indigenous Australians With Type 2 Diabetes, Enrolled in a Randomised Controlled Trial of Rosiglitazone Versus Metformin Monotherapy to Assess the Effects on Metabolic and Cardiovascular Parameters |
| Lead sponsor | Menzies School of Health Research, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Pioglitazone, Metformin |
| Enrollment | 0 |
| Start date | Apr 1, 2008 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 21, 2007 |
| Last update posted | May 27, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: